» Articles » PMID: 949182

Activity of Cefamandole and Other Cephalosporins Against Aerobic and Anaerobic Bacteria

Overview
Specialty Pharmacology
Date 1976 May 1
PMID 949182
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

The activity of cefamandole was comparable to that of cephalothin, cefazolin, and cephaloridine against Staphylococcus aureus, Streptococcus pyogenes, and Diplococcus pneumoniae. In contrast, cefamandole was considerably more active than cephalothin, cefazolin, or cephaloridine against gram-negative facultative bacilli, including Haemophilus influenzae, the most striking disparities being noted with indole-positive Proteus and Enterobacter. Bacteroides fragilis was more susceptible to cefoxitin than to cefamandole or cefazolin (median minimal inhibitory concentration, approximately 8, 32, and 32 mug/ml, respectively); cephalothin exhibited still less activity against this species. The majority of other anaerobes were inhibited by relatively low concentrations of all four cephalosporins. The results indicate a potentially valuable role for cefamandole against facultative gram-negative bacilli, including H. influenzae, but no exceptional activity against anaerobes.

Citing Articles

The Chemical Relationship Among Beta-Lactam Antibiotics and Potential Impacts on Reactivity and Decomposition.

Turner J, Muraoka A, Bedenbaugh M, Childress B, Pernot L, Wiencek M Front Microbiol. 2022; 13:807955.

PMID: 35401470 PMC: 8988990. DOI: 10.3389/fmicb.2022.807955.


Bacteroides fragilis septicemia during cefamandole therapy.

Righter J Can Med Assoc J. 1981; 125(5):422, 424.

PMID: 7284925 PMC: 1862477.


Characterization of pBFTM10, a clindamycin-erythromycin resistance transfer factor from Bacteroides fragilis.

Tally F, Snydman D, Shimell M, MALAMY M J Bacteriol. 1982; 151(2):686-91.

PMID: 7096266 PMC: 220309. DOI: 10.1128/jb.151.2.686-691.1982.


Methodological implications of testing anaerobe susceptibility to cephalosporins (cefazolin, cefamandole, cefoxitin).

Krasemann C, Werner H, Hildenbrand G, Benning M, Brandt U, Ungerechts J Infection. 1980; 8 Suppl 2:S182-6.

PMID: 6969693 DOI: 10.1007/BF01639888.


Clinical experience with Moxalactam in the treatment of pseudomonal and nonpseudomonal infections.

Murphy T, Barza M Antimicrob Agents Chemother. 1982; 21(4):568-74.

PMID: 6211137 PMC: 181943. DOI: 10.1128/AAC.21.4.568.


References
1.
Neu H . Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity. Antimicrob Agents Chemother. 1974; 6(2):177-82. PMC: 444624. DOI: 10.1128/AAC.6.2.177. View

2.
Bergeron M, Brusch J, Barza M, WEINSTEIN L . Bactericidal activity and pharmacology of cefazolin. Antimicrob Agents Chemother. 1973; 4(4):396-401. PMC: 444566. DOI: 10.1128/AAC.4.4.396. View

3.
Eykyn S, Phillips I . Letter: Sensitivity of haemophilus influenzae to cephalosporins. Br Med J. 1974; 2(5909):59. PMC: 1610121. DOI: 10.1136/bmj.2.5909.59. View

4.
Williams J, Andrews J . Sensitivity of Haemophilus influenzae to antibiotics. Br Med J. 1974; 1(5899):134-7. PMC: 1633005. DOI: 10.1136/bmj.1.5899.134. View

5.
Eykyn S, Jenkins C, King A, Phillips I . Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin. Antimicrob Agents Chemother. 1973; 3(6):657-61. PMC: 444475. DOI: 10.1128/AAC.3.6.657. View